Marine Pharmacology in 2005-6: Marine Compounds with Anthelmintic, Antibacterial, Anticoagulant, Antifungal, Anti-inflammatory, Antimalarial, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Cardiovascular, Immune and Nervous...

Overview

Journal Biochim Biophys Acta

Specialties Biochemistry
Biophysics

Date 2009 Mar 24

PMID 19303911

Citations 69

Authors

Alejandro M S Mayer

Abimael D Rodriguez

Roberto G S Berlinck

Mark T Hamann

Affiliations

Soon will be listed here.

Abstract

Background: The review presents the 2005-2006 peer-reviewed marine pharmacology literature, and follows a similar format to the authors' 1998-2004 reviews. The preclinical pharmacology of chemically characterized marine compounds isolated from marine animals, algae, fungi and bacteria is systematically presented.

Results: Anthelmintic, antibacterial, anticoagulant, antifungal, antimalarial, antiprotozoal, antituberculosis and antiviral activities were reported for 78 marine chemicals. Additionally 47 marine compounds were reported to affect the cardiovascular, immune and nervous system as well as possess anti-inflammatory effects. Finally, 58 marine compounds were shown to bind to a variety of molecular targets, and thus could potentially contribute to several pharmacological classes.

Conclusions: Marine pharmacology research during 2005-2006 was truly global in nature, involving investigators from 32 countries, and the United States, and contributed 183 marine chemical leads to the research pipeline aimed at the discovery of novel therapeutic agents.

General Significance: Continued preclinical and clinical research with marine natural products demonstrating a broad spectrum of pharmacological activity will probably result in novel therapeutic agents for the treatment of multiple disease categories.

Citing Articles

Investigation the effect of the aqueous extract of (L.) on visceral leishmaniasis.

Ghusoon A, Buthaina A Trop Parasitol. 2024; 14(2):84-94.

PMID: 39411680 PMC: 11473012. DOI: 10.4103/tp.tp_1_24.

Marine Pharmacology in 2019-2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous....

Mayer A, Mayer V, Swanson-Mungerson M, Pierce M, Rodriguez A, Nakamura F Mar Drugs. 2024; 22(7).

PMID: 39057418 PMC: 11278370. DOI: 10.3390/md22070309.

Exploring the Antimicrobial Potential and Biofilm Inhibitory Properties of Hemocyanin from (Born, 1778).

Jeyachandran S, Chellapandian H, Park K, Kwak I Int J Mol Sci. 2023; 24(14).

PMID: 37511256 PMC: 10380319. DOI: 10.3390/ijms241411494.

Antiviral activity of red algae phycocolloids against herpes simplex virus type 2 .

Henriquez A, Vargas J, Landahur C, Corrales N, Agurto-Munoz A, Gonzalez P Biotechnol Rep (Amst). 2023; 38:e00798.

PMID: 37181274 PMC: 10172717. DOI: 10.1016/j.btre.2023.e00798.

Advances in Natural Products from the Marine-Sponge-Associated Microorganisms with Antimicrobial Activity in the Last Decade.

Liang J, She J, Fu J, Wang J, Ye Y, Yang B Mar Drugs. 2023; 21(4).

PMID: 37103375 PMC: 10143917. DOI: 10.3390/md21040236.

References

Krohn K, Dai J, Florke U, Aust H, Drager S, Schulz B . Botryane metabolites from the fungus Geniculosporium sp. isolated from the marine red alga Polysiphonia. J Nat Prod. 2005; 68(3):400-5. DOI: 10.1021/np0498206. View

Sauleau P, Bourguet-Kondracki M . Novel polyhydroxysterols from the Red Sea marine sponge Lamellodysidea herbacea. Steroids. 2005; 70(14):954-9. DOI: 10.1016/j.steroids.2005.07.004. View

Sugiyama N, Araki M, Ishida M, Nagashima Y, Shiomi K . Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus. Toxicon. 2005; 45(5):595-601. DOI: 10.1016/j.toxicon.2004.12.021. View

Cao S, Foster C, Brisson M, Lazo J, Kingston D . Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp. Bioorg Med Chem. 2005; 13(4):999-1003. DOI: 10.1016/j.bmc.2004.11.039. View

Kim T, Hewavitharana A, Shaw P, Fuerst J . Discovery of a new source of rifamycin antibiotics in marine sponge actinobacteria by phylogenetic prediction. Appl Environ Microbiol. 2006; 72(3):2118-25. PMC: 1393243. DOI: 10.1128/AEM.72.3.2118-2125.2006. View

Nam S, Ko H, Shin M, Ham J, Chin J, Kim Y . Farnesoid X-activated receptor antagonists from a marine sponge Spongia sp. Bioorg Med Chem Lett. 2006; 16(20):5398-402. DOI: 10.1016/j.bmcl.2006.07.079. View

Li X, Jacob M, Ding Y, Agarwal A, Smillie T, Khan S . Capisterones A and B, which enhance fluconazole activity in Saccharomyces cerevisiae, from the marine green alga Penicillus capitatus. J Nat Prod. 2006; 69(4):542-6. PMC: 2631560. DOI: 10.1021/np050396y. View

Sasaki M, Tsuda M, Sekiguchi M, Mikami Y, Kobayashi J . Perinadine A, a novel tetracyclic alkaloid from marine-derived fungus Penicillium citrinum. Org Lett. 2005; 7(19):4261-4. DOI: 10.1021/ol051695h. View

Marion F, Williams D, Patrick B, Hollander I, Mallon R, Kim S . Liphagal, a Selective inhibitor of PI3 kinase alpha isolated from the sponge akacoralliphaga: structure elucidation and biomimetic synthesis. Org Lett. 2006; 8(2):321-4. DOI: 10.1021/ol052744t. View

10.

Mayer A, Hamann M . Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and.... Mar Biotechnol (NY). 2003; 6(1):37-52. PMC: 4934889. DOI: 10.1007/s10126-003-0007-7. View

11.

Aiello A, DEsposito M, Fattorusso E, Menna M, Muller W, Perovic-Ottstadt S . Novel bioactive bromopyrrole alkaloids from the Mediterranean sponge Axinella verrucosa. Bioorg Med Chem. 2005; 14(1):17-24. DOI: 10.1016/j.bmc.2005.07.057. View

12.

von Elert E, Oberer L, Merkel P, Huhn T, Blom J . Cyanopeptolin 954, a chlorine-containing chymotrypsin inhibitor of Microcystis aeruginosa NIVA Cya 43. J Nat Prod. 2005; 68(9):1324-7. DOI: 10.1021/np050079r. View

13.

Dubuisson M, Rees J, Marchand-Brynaert J . Coelenterazine (marine bioluminescent substrate): a source of inspiration for the discovery of novel antioxidants. Drug Dev Ind Pharm. 2005; 31(9):827-49. DOI: 10.1080/03639040500271803. View

14.

Matsuhiro B, Conte A, Damonte E, Kolender A, Matulewicz M, Mejias E . Structural analysis and antiviral activity of a sulfated galactan from the red seaweed Schizymenia binderi (Gigartinales, Rhodophyta). Carbohydr Res. 2005; 340(15):2392-402. DOI: 10.1016/j.carres.2005.08.004. View

15.

Okada Y, Matsunaga S, Soest R, Fusetani N . Sokodosides, steroid glycosides with an isopropyl side chain, from the marine sponge Erylus placenta. J Org Chem. 2006; 71(13):4884-8. DOI: 10.1021/jo060653j. View

16.

Wang W, Okada Y, Shi H, Wang Y, Okuyama T . Structures and aldose reductase inhibitory effects of bromophenols from the red alga Symphyocladia latiuscula. J Nat Prod. 2005; 68(4):620-2. DOI: 10.1021/np040199j. View

17.

Linington R, Robertson M, Gauthier A, Finlay B, MacMillan J, Molinski T . Caminosides B-D, antimicrobial glycolipids isolated from the marine sponge Caminus sphaeroconia. J Nat Prod. 2006; 69(2):173-7. DOI: 10.1021/np050192h. View

18.

Dai H, Edrada R, Ebel R, Nimtz M, Wray V, Proksch P . Norlanostane triterpenoidal saponins from the marine sponge melophlussarassinorum. J Nat Prod. 2005; 68(8):1231-7. DOI: 10.1021/np050152d. View

19.

de Souza M . Marine natural products against tuberculosis. ScientificWorldJournal. 2006; 6:847-61. PMC: 5917141. DOI: 10.1100/tsw.2006.174. View

20.

Mayer A, Gustafson K . Marine pharmacology in 2001-2: antitumour and cytotoxic compounds. Eur J Cancer. 2004; 40(18):2676-704. DOI: 10.1016/j.ejca.2004.09.005. View